Surgical resection of advanced gastric cancer following trastuzumab/oxaliplatin/capecitabine combination therapy

doi:10.3748/wjg.v20.i34.12355

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 34

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5727)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

353

WORD

195

HTML

2994

Figures (1-2)

200

Sum=3742

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

945

Download

1040

Sum=1985

Sep 14, 2014 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Sep 14, 2014; 20(34): 12355-12358
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12355

Full Size Figure Download Figure

Figure 1 Fluorescence in situ hybridization analysis showing positive human epidermal growth factor receptor 2 expression with cluster amplification (ratio > 2. 2).

Citation: Dong CX, Fu JF, Ye XY, Li XF, Zhong X, Yuan Y. Surgical resection of advanced gastric cancer following trastuzumab/oxaliplatin/capecitabine combination therapy. World J Gastroenterol 2014; 20(34): 12355-12358
URL: https://www.wjgnet.com/1007-9327/full/v20/i34/12355.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i34.12355